In our inaugural episode we are discussing integrated evidence generation planning (IEGP) in the pharmaceutical industry featuring our AESARA Europe Managing Director, Gavin Outteridge.

Time Stamps:

1:13 - 7:16 Defining IEGP and its Benefits

7:24 - 11:00 Shortcomings in the current evidence generation approach

11:13 - 14:45 Impact on patient outcomes

15:04 - 20:29 Challenges to the IEGP process

20:43 - 23:35 Use of technology to improve process & closing comments

Resources:

Developing an integrated strategy for evidence generation (https://tinyurl.com/43zuamvv)